Efficacy and Safety of Everolimus with Reduced-Exposure Tacrolimus and Corticosteroid Withdrawal in De Novo Pediatric Renal Transplant Recipients: 12-Month Results from the CRADLE Study

被引:0
|
作者
Ettenger, R. [1 ]
Tonshoff, B. [1 ]
Tedesco, H. [1 ]
Dello Strologo, L. [1 ]
Marks, S. [1 ]
Pape, L. [1 ]
Martzloff, E. [2 ]
Rauer, B. [2 ]
Ng, J. [3 ]
Lopez, P. [2 ]
机构
[1] A2314 Study Grp, Los Angeles, CA USA
[2] Novartis Pharma AG, Basel, Switzerland
[3] Nova Pharmaceut Corp, E Hanover, NJ USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
569
引用
收藏
页码:407 / 408
页数:2
相关论文
共 50 条
  • [1] PRESERVATION OF RENAL FUNCTION WITH EVEROLIMUS PLUS REDUCED-DOSE TACROLIMUS AND CORTICOSTEROID WITHDRAWAL-BASED REGIMEN IN DE NOVO PEDIATRIC RENAL TRANSPLANT RECIPIENTS: 12-MONTH RESULTS FROM THE CRADLE STUDY
    Toenshoff, Burkhard
    Ettenger, Robert
    Dello Strologo, Luca
    Marks, Stephen D.
    Pape, Lars
    Christian, Martin
    Mathe, Zoltan
    Martzloff, El-djouher
    Rauer, Barbara
    Ng, Jennifer
    Meier, Matthias
    Lopez, Patricia M.
    [J]. PEDIATRIC NEPHROLOGY, 2017, 32 (09) : 1798 - 1800
  • [2] 12-month safety and efficacy of everolimus with reduced exposure cyclosporine in de novo renal transplant recipients
    Tedesco-Silva, Helio, Jr.
    Vitko, Stefan
    Pascual, Julio
    Eris, Josette
    Magee, John C.
    Whelchel, John
    Civati, Giovanni
    Campbell, Scott
    Alves-Filho, Gentil
    Bourbigot, Bernard
    Garcia, Valter Duro
    Leone, John
    Esmeraldo, Ronaldo
    Rigotti, Paolo
    Cambi, Vincenzo
    Haas, Tomas
    [J]. TRANSPLANT INTERNATIONAL, 2007, 20 (01) : 27 - 36
  • [3] EFFICACY AND SAFETY OF EVEROLIMUS WITH REDUCED TACROLIMUS AND EARLY STEROID ELIMINATION REGIMEN IN DE NOVO PEDIATRIC RENAL TRANSPLANT RECIPIENTS: 12-MONTH DATA FROM THE CRADLE STUDY.
    Toenshoff, B.
    Ettenger, R.
    Christian, M.
    Bjerre, A.
    Strologo, L. D.
    Marks, S. D.
    Pape, L.
    Martzloff, E-D.
    Rauer, B.
    Ng, J.
    Lopez, P. M.
    [J]. PEDIATRIC TRANSPLANTATION, 2017, 21 : 1 - 1
  • [4] RENAL FUNCTION OUTCOMES OF EVEROLIMUS WITH REDUCED-DOSE TACROLIMUS AND CORTICOSTEROID WITHDRAWAL-BASED REGIMEN IN DE NOVO PEDIATRIC RENAL TRANSPLANT RECIPIENTS: 12-MONTH ANALYSIS OF THE CRADLE STUDY.
    Tedesco, H.
    Toenshoff, B.
    Ettenger, R.
    Wennberg, L.
    Strologo, L. D.
    Marks, S. D.
    Pape, L.
    Martzloff, E-D.
    Rauer, B.
    Ng, J.
    Lopez, P. M.
    [J]. PEDIATRIC TRANSPLANTATION, 2017, 21 : 1 - 1
  • [5] Efficacy and Safety of Everolimus With Low-Dose Tacrolimus in De Novo Renal Transplant Recipients: 12-Month Randomized Study
    Qazi, Y.
    Shaffer, D.
    Kaplan, B.
    Kim, D.
    Luan, F.
    Peddi, V.
    Shihab, F.
    Tomlanovich, S.
    Yilmaz, S.
    McCague, K.
    Patel, D.
    Mulgaonkar, S.
    [J]. TRANSPLANTATION, 2014, 98 : 80 - 80
  • [6] PRESERVATION OF RENAL FUNCTION WITH EVEROLIMUS PLUS REDUCED TACROLIMUS AND CORTICOSTEROID WITHDRAWAL-BASED REGIMEN IN DE NOVO PEDIATRIC RENAL TRANSPLANT RECIPIENTS: 12-MONTHS RESULTS: THE CRADLE STUDY
    Toenshoff, B.
    Ettenger, R.
    Dello Strologo, L.
    Marks, S. D.
    Pape, L.
    Christian, M.
    Mathe, Z.
    Martzloff, E. D.
    Rauer, B.
    Ng, J.
    Meier, M.
    Lopez, P. M.
    [J]. TRANSPLANT INTERNATIONAL, 2017, 30 : 22 - 22
  • [7] Efficacy and Safety of Everolimus With Low-Dose Tacrolimus in De Novo Renal Transplant Recipients: 12-Month Randomized Study
    Qazi, Y.
    Shaffer, D.
    Kaplan, B.
    Kim, D.
    Luan, F.
    Peddi, V.
    Shihab, F.
    Tomlanovich, S.
    Yilmaz, S.
    McCague, K.
    Patel, D.
    Mulgaonkar, S.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 80 - 80
  • [8] THE TRANSFORM STUDY: EFFECT OF EVEROLIMUS WITH REDUCED-EXPOSURE CALCINEURIN INHIBITOR ON 12-MONTH RENAL FUNCTION OUTCOMES IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS
    Oppenheimer, Federico
    Witzke, Oliver
    Viklicky, Ondrej
    Cassuto, Elisabeth
    De Fijter, Johan
    Huynh-Do, Uyen
    Russ, Graeme
    Srinivas, Titte
    Luo, Wen-Lin
    Bernhardt, Peter
    Qazi, Yasir
    [J]. TRANSPLANT INTERNATIONAL, 2017, 30 : 162 - 162
  • [9] Efficacy and Safety of Everolimus with Reduced Tacrolimus or Cyclosporine in Pediatric Liver Transplant Recipients: 12-Month Results from H2305 Study
    Weymann, A.
    Ganschow, R.
    Ericzon, B.
    Dhawan, A.
    Sharif, K.
    Martzloff, E. -D.
    Rauer, B.
    Ng, J.
    Lopez, P.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 234 - 234
  • [10] THE TRANSFORM STUDY: 12-MONTH EFFICACY AND SAFETY OF EVEROLIMUS WITH REDUCED CALCINEURIN INHIBITOR IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS
    Pascual, Julio
    Berger, Stefan
    Witzke, Oliver
    Chadban, Steve
    Oppenheimer, Federico
    Oberbauer, Rainer
    Watarai, Yoshihiko
    Legendre, Christophe
    Luo, Wen-Lin
    Marti, Anamaria
    Bernhardt, Peter
    Tedesco, Helio
    [J]. TRANSPLANT INTERNATIONAL, 2017, 30 : 159 - 159